Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 1 | 2 | +1 |
| Shares | 14.1K | 300 | −13.8K (−97.9%) |
| Value | $1.44K | $10 | −$1.43K (−99.3%) |
New holders (2)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bartlett & Co. Wealth Management LLC | 150 | $10 | 0.00% |
| Bartlett & Co. LLC | 150 | $0 | 0.00% |
Sold out (1)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Wealth Architects, LLC | 14,077 | $1.44K |